Jacobs Levy Equity Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,675,373
| Closed | -$19.4M | – | 1024 |
|
|
2021
Q4 | $19.4M | Sell |
1,675,373
-134,419
| -7% | -$1.55M | 0.13% | 191 |
|
|
2021
Q3 | $17.3M | Buy |
1,809,792
+84,264
| +5% | +$805K | 0.12% | 207 |
|
|
2021
Q2 | $16.6M | Buy |
1,725,528
+1,467,313
| +568% | +$14.1M | 0.11% | 219 |
|
|
2021
Q1 | $2.55M | Buy |
+258,215
| New | +$2.55M | 0.02% | 547 |
|
|
2020
Q1 | – | Sell |
-181,176
| Closed | -$1.77M | – | 1035 |
|
|
2019
Q4 | $1.77M | Buy |
181,176
+162,076
| +849% | +$1.58M | 0.02% | 569 |
|
|
2019
Q3 | $153K | Buy |
19,100
+1,900
| +11% | +$15.2K | ﹤0.01% | 866 |
|
|
2019
Q2 | $215K | Buy |
+17,200
| New | +$215K | ﹤0.01% | 868 |
|
|
2018
Q4 | – | Sell |
-74,724
| Closed | -$903K | – | 1011 |
|
|
2018
Q3 | $903K | Buy |
74,724
+21,624
| +41% | +$261K | 0.01% | 666 |
|
|
2018
Q2 | $829K | Buy |
+53,100
| New | +$829K | 0.01% | 705 |
|
|
2014
Q4 | – | Sell |
-55,885
| Closed | -$333K | – | 852 |
|
|
2014
Q3 | $333K | Sell |
55,885
-10,515
| -16% | -$62.7K | 0.01% | 659 |
|
|
2014
Q2 | $222K | Buy |
+66,400
| New | +$222K | ﹤0.01% | 751 |
|
|
2014
Q1 | – | Sell |
-28,912
| Closed | -$68K | – | 929 |
|
|
2013
Q4 | $68K | Sell |
28,912
-106,134
| -79% | -$250K | ﹤0.01% | 918 |
|
|
2013
Q3 | $313K | Buy |
+135,046
| New | +$313K | 0.01% | 785 |
|